Bioactive molecules, often small organic compounds, produced through metabolic processes that actively suppress or resolve chronic systemic inflammation. These metabolites are crucial mediators in maintaining immune balance and preventing the detrimental effects of prolonged inflammatory signaling on tissues and organs. They are frequently derived from dietary components or the actions of the gut microbiome.
Origin
The term is rooted in biochemistry and immunology, combining the concept of “metabolites,” the intermediate or end products of metabolism, with their demonstrable “anti-inflammatory” biological activity. The study of these compounds has gained prominence with the recognition of chronic inflammation as a key driver of age-related disease and hormonal dysfunction.
Mechanism
These metabolites function by modulating the activity of key inflammatory transcription factors, such as Nuclear Factor-kappa B (NF-κB), reducing the production of pro-inflammatory cytokines like Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-α). Short-chain fatty acids (SCFAs) produced by the gut microbiota are prime examples, acting on G-protein coupled receptors in immune cells to promote a state of immunological tolerance. Effective utilization of these agents supports a healthier endocrine environment by minimizing inflammatory stress.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.